Corteva (NYSE:CTVA) Issues FY 2025 Earnings Guidance

Corteva (NYSE:CTVA) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 2.700-2.950 for the period, compared to the consensus estimate of 3.190. The company issued revenue guidance of $17.2 billion-$17.6 billion, compared to the consensus revenue estimate of $17.3 billion.

Corteva Price Performance

NYSE CTVA traded down $2.08 during trading on Wednesday, hitting $63.62. 8,909,398 shares of the company’s stock were exchanged, compared to its average volume of 3,400,137. The company has a market cap of $43.72 billion, a PE ratio of 64.26, a P/E/G ratio of 1.71 and a beta of 0.78. The company has a current ratio of 1.50, a quick ratio of 0.96 and a debt-to-equity ratio of 0.08. Corteva has a fifty-two week low of $50.01 and a fifty-two week high of $66.24. The stock’s 50 day moving average price is $60.20 and its two-hundred day moving average price is $58.07.

Corteva (NYSE:CTVA) last posted its earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 4.18% and a return on equity of 6.63%. Research analysts expect that Corteva will post 2.58 EPS for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, March 17th. Shareholders of record on Monday, March 3rd will be given a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.07%. The ex-dividend date of this dividend is Monday, March 3rd. Corteva’s dividend payout ratio is presently 68.69%.

Corteva declared that its Board of Directors has authorized a share repurchase program on Tuesday, November 19th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the company to buy up to 7.5% of its shares through open market purchases. Shares buyback programs are typically a sign that the company’s leadership believes its shares are undervalued.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the stock. Bank of America boosted their target price on shares of Corteva from $67.00 to $69.00 and gave the company a “buy” rating in a research report on Wednesday, November 20th. UBS Group cut their price objective on shares of Corteva from $74.00 to $73.00 and set a “buy” rating on the stock in a research report on Friday, January 10th. Wells Fargo & Company boosted their target price on Corteva from $67.00 to $73.00 and gave the company an “overweight” rating in a research report on Tuesday, January 28th. Barclays raised their price objective on Corteva from $62.00 to $64.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 21st. Finally, KeyCorp cut their target price on Corteva from $69.00 to $68.00 and set an “overweight” rating on the stock in a report on Friday, January 10th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $67.06.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.